Literature DB >> 22906125

Interrogation of brain miRNA and mRNA expression profiles reveals a molecular regulatory network that is perturbed by mutant huntingtin.

Jing Jin1, Yong Cheng, Yongqing Zhang, William Wood, Qi Peng, Emmette Hutchison, Mark P Mattson, Kevin G Becker, Wenzhen Duan.   

Abstract

Emerging evidence indicates that microRNAs (miRNAs) may play an important role in the pathogenesis of Huntington's disease (HD). To identify the individual miRNAs that are altered in HD and may therefore regulate a gene network underlying mutant huntingtin-induced neuronal dysfunction in HD, we performed miRNA array analysis combined with mRNA profiling in the cerebral cortex from N171-82Q HD mice. Expression profiles of miRNAs as well as mRNAs in HD mouse cerebral cortex were analyzed and confirmed at different stages of disease progression; the most significant changes of miRNAs in the cerebral cortex were also detected in the striatum of HD mice. Our results revealed a significant alteration of miR-200 family members, miR-200a, and miR-200c in the cerebral cortex and the striatum, at the early stage of disease progression in N171-82Q HD mice. We used a coordinated approach to integrate miRNA and mRNA profiling, and applied bioinformatics to predict a target gene network potentially regulated by these significantly altered miRNAs that might be involved in HD disease progression. Interestingly, miR-200a and miR-200c are predicted to target genes regulating synaptic function, neurodevelopment, and neuronal survival. Our results suggest that altered expression of miR-200a and miR-200c may interrupt the production of proteins involved in neuronal plasticity and survival, and further investigation of the involvement of perturbed miRNA expression in HD pathogenesis is warranted, and may lead to reveal novel approaches for HD therapy.
© 2012 The Authors Journal of Neurochemistry © 2012 International Society for Neurochemistry.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22906125      PMCID: PMC3472040          DOI: 10.1111/j.1471-4159.2012.07925.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  62 in total

1.  Altered microRNAs in STHdh(Q111)/Hdh(Q111) cells: miR-146a targets TBP.

Authors:  Mithun Sinha; Jayeeta Ghose; Eashita Das; Nitai P Bhattarcharyya
Journal:  Biochem Biophys Res Commun       Date:  2010-05-06       Impact factor: 3.575

Review 2.  miRNA and neurons.

Authors:  S Trivedi; G Ramakrishna
Journal:  Int J Neurosci       Date:  2009       Impact factor: 2.292

3.  Decreased expression of striatal signaling genes in a mouse model of Huntington's disease.

Authors:  R Luthi-Carter; A Strand; N L Peters; S M Solano; Z R Hollingsworth; A S Menon; A S Frey; B S Spektor; E B Penney; G Schilling; C A Ross; D R Borchelt; S J Tapscott; A B Young; J H Cha; J M Olson
Journal:  Hum Mol Genet       Date:  2000-05-22       Impact factor: 6.150

4.  Dopamine D1 and D2 receptor gene expression in the striatum in Huntington's disease.

Authors:  S J Augood; R L Faull; P C Emson
Journal:  Ann Neurol       Date:  1997-08       Impact factor: 10.422

5.  Nuclear factor one transcription factors in CNS development.

Authors:  Sharon Mason; Michael Piper; Richard M Gronostajski; Linda J Richards
Journal:  Mol Neurobiol       Date:  2008-12-05       Impact factor: 5.590

6.  Reversal of behavioral and metabolic abnormalities, and insulin resistance syndrome, by dietary restriction in mice deficient in brain-derived neurotrophic factor.

Authors:  Wenzhen Duan; Zhihong Guo; Haiyang Jiang; Melvin Ware; Mark P Mattson
Journal:  Endocrinology       Date:  2003-06       Impact factor: 4.736

7.  Involvement of the PRKCB1 gene in autistic disorder: significant genetic association and reduced neocortical gene expression.

Authors:  C Lintas; R Sacco; K Garbett; K Mirnics; R Militerni; C Bravaccio; P Curatolo; B Manzi; C Schneider; R Melmed; M Elia; T Pascucci; S Puglisi-Allegra; K-L Reichelt; A M Persico
Journal:  Mol Psychiatry       Date:  2008-03-04       Impact factor: 15.992

8.  A microRNA-based gene dysregulation pathway in Huntington's disease.

Authors:  Rory Johnson; Chiara Zuccato; Nikolai D Belyaev; Deborah J Guest; Elena Cattaneo; Noel J Buckley
Journal:  Neurobiol Dis       Date:  2007-11-13       Impact factor: 5.996

9.  Targeting Huntington's disease through histone deacetylases.

Authors:  Steven G Gray
Journal:  Clin Epigenetics       Date:  2011-02-18       Impact factor: 6.551

10.  Down-regulation of the dopamine receptor D2 in mice lacking ataxin 1.

Authors:  Robert Goold; Michael Hubank; Abigail Hunt; Janice Holton; Rajesh P Menon; Tamas Revesz; Massimo Pandolfo; Antoni Matilla-Dueñas
Journal:  Hum Mol Genet       Date:  2007-06-28       Impact factor: 6.150

View more
  29 in total

1.  Alterations in Striatal microRNA-mRNA Networks Contribute to Neuroinflammation in Multiple System Atrophy.

Authors:  Taeyeon Kim; Elvira Valera; Paula Desplats
Journal:  Mol Neurobiol       Date:  2019-04-09       Impact factor: 5.590

2.  MicroRNA expressions associated with eosinophilic meningitis caused by Angiostrongylus cantonensis infection in a mouse model.

Authors:  L Yu; Q Liao; X Zeng; Z Lv; H Zheng; Y Zhao; X Sun; Z Wu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-03-30       Impact factor: 3.267

3.  miR-25 alleviates polyQ-mediated cytotoxicity by silencing ATXN3.

Authors:  Fengzhen Huang; Li Zhang; Zhe Long; Zhao Chen; Xuan Hou; Chunrong Wang; Huirong Peng; Junling Wang; Jiada Li; Ranhui Duan; Kun Xia; De-Maw Chuang; Beisha Tang; Hong Jiang
Journal:  FEBS Lett       Date:  2014-11-20       Impact factor: 4.124

4.  Copper-Induced Upregulation of MicroRNAs Directs the Suppression of Endothelial LRP1 in Alzheimer's Disease Model.

Authors:  Heng-Wei Hsu; Carlos J Rodriguez-Ortiz; Siok Lam Lim; Joannee Zumkehr; Jason G Kilian; Janielle Vidal; Masashi Kitazawa
Journal:  Toxicol Sci       Date:  2019-07-01       Impact factor: 4.849

Review 5.  miRNAs: Key Players in Neurodegenerative Disorders and Epilepsy.

Authors:  Hanuma Kumar Karnati; Manas Kumar Panigrahi; Ravi Kumar Gutti; Nigel H Greig; Ian A Tamargo
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

Review 6.  Current Update on Synopsis of miRNA Dysregulation in Neurological Disorders.

Authors:  Mohammad A Kamal; Gohar Mushtaq; Nigel H Greig
Journal:  CNS Neurol Disord Drug Targets       Date:  2015       Impact factor: 4.388

7.  Wide Profiling of Circulating MicroRNAs in Spinocerebellar Ataxia Type 7.

Authors:  Verónica M Borgonio-Cuadra; Claudia Valdez-Vargas; Sandra Romero-Córdoba; Alfredo Hidalgo-Miranda; Yessica Tapia-Guerrero; César M Cerecedo-Zapata; Oscar Hernández-Hernández; Bulmaro Cisneros; Jonathan J Magaña
Journal:  Mol Neurobiol       Date:  2019-02-05       Impact factor: 5.590

8.  Postnatal and adult consequences of loss of huntingtin during development: Implications for Huntington's disease.

Authors:  Eduardo E Arteaga-Bracho; Maria Gulinello; Michael L Winchester; Nandini Pichamoorthy; Jenna R Petronglo; Alicia D Zambrano; Julio Inocencio; Chirstopher D De Jesus; Joseph O Louie; Solen Gokhan; Mark F Mehler; Aldrin E Molero
Journal:  Neurobiol Dis       Date:  2016-09-10       Impact factor: 5.996

9.  Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease.

Authors:  Lan Lin; Juw Won Park; Shyam Ramachandran; Yida Zhang; Yu-Ting Tseng; Shihao Shen; Henry J Waldvogel; Maurice A Curtis; Richard L M Faull; Juan C Troncoso; Olga Pletnikova; Christopher A Ross; Beverly L Davidson; Yi Xing
Journal:  Hum Mol Genet       Date:  2016-07-04       Impact factor: 6.150

Review 10.  Cell-Autonomous and Non-cell-Autonomous Pathogenic Mechanisms in Huntington's Disease: Insights from In Vitro and In Vivo Models.

Authors:  Jordi Creus-Muncunill; Michelle E Ehrlich
Journal:  Neurotherapeutics       Date:  2019-10       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.